Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Ascletis, Beigene, Direct Biologics, Iaso, Kiniksa, Kyowa Kirin, Moderna, Ocugen, RDIF, Takeda, Vicore.